NeuroSense Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

뉴로센스 테라퓨틱스NASDAQ:NRSN · Nasdaq · Healthcare

$3.94-2.84%

2026-10-02 close

NeuroSense Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$10M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy